Navigation Links
Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share
Date:8/7/2008

come tax expense 48 26 65 35

Minority interest income (loss),

net of taxes 1 - 1 (2)

Net earnings from continuing

operations 57 46 80 59

Net loss from discontinued

operations, net of taxes - (1) - (2)

Net earnings $57 $45 $80 $57

Earnings per common share - diluted:

Earnings per common share -

continuing operations $0.52 $0.42 $0.73 $0.54

Loss per common share - discontinued

operations - (0.01) - (0.02)

Net earnings per common share -

diluted $0.52 $0.41 $0.73 $0.52

Weighted average shares - assuming

dilution 109 108 109 108

Stock-based compensation expense:

Cost of sales $3 $2 $5 $4

Selling, general and administrative 5 5 8 8

Research and development 2 1 3 3

Total stock-based compensation

expense $10 $8 $16 $15

$ in millions As of As of

June 30, Dec. 31,

2008 2007

Cash & cash equivalents $513 $246

Marketable securities - current 34 288

Account receivable, net 580 497

Other receivables 98 86

Inventories 471 454

Marketable securities - long-term 21 17

Accounts payable & accrued

liabilities 442 443

Working capital
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
2. Caliper Life Sciences Reports Second Quarter 2008 Results
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. EntreMed Reports Second Quarter 2008 Financial Results
5. Transgenomic Reports Second Quarter 2008 Results
6. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
7. Bionovo Reports Second Quarter 2008 Financial Results
8. AtriCure Reports Record Second Quarter 2008 Financial Results
9. AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
10. eResearchTechnology Reports Second Quarter 2008 Results
11. SuperGen Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces the ... office space for Shire a leading biopharmaceutical company, at Two ... | RBJ,s Robert Richards , president, and Brian ... for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... The laboratory information management systems market is ... of technological advancements due to factors such as rising ... integrate healthcare systems, and increasing government support for adoption ... Key players in the market focus on technological advancements ...
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics ... from a new partner. STT-Systems has developed an ... years, with offerings in the optical-motion capture, 3D scanning, and ... measurement unit), iSen, is opening eyes around the world. With ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... - Worldwide Net Revenue Increased 4% for the 2008 Third Quarter and ... - Third Quarter Revenue Growth in Pharmaceuticals Division Led by ... and Prevnar +13% , - Guidance for 2008 Full ... Items, Revised to a Range of $3.49 to $3.55 , ...
... - Updated Results Presented at 20th EORTC-NCI-AACR ... and GENEVA, Oct. 22 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, ... focused on oncology, today announced positive incremental ... of picoplatin in combination with,docetaxel and prednisone ...
... of Health, SAN DIEGO, Oct. 22 ... $28 million contract from the National Institute,of Allergy ... National,Institutes of Health, for the development of novel ... five-year,contract, Trius will develop novel drugs targeting bacterial ...
Cached Biology Technology:Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 2Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 4Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 5Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 6Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 7Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 8Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 9Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 10Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 11Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 12Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 13Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 14Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 2Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 3Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 4Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 5Trius Awarded $28 Million Contract to Develop Novel Antibiotics 2
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the ... Security Systems Market" report to their offering. ... perimeter security market is estimated to grow at a CAGR ... holds a larger share in this market, Canada ...
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ...
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 The ... it easier to detect and prevent counterfeit microcircuits from ... agency started performing an in-house microcircuit anti-counterfeit initiative dubbed ... purchased microcircuits while increasing their reliability throughout the supply ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... sandpipers ( Calidris pusilla ) feeding during low tide ... Beauchamp, an ornithologist and research officer at the University ... the periphery remained alert and used short pecks to ... the group relaxed their vigilance and fed on a ...
... are the heart of the smaller, better electronics ... new materials, medical diagnostics and therapeutics, energy storage, ... have unintended consequences for human health and the ... and policy makers, the Virginia Tech Center for ...
... long lasting, possibly permanent, performance-enhancing effects, shows a study ... Physiology ., Previously, re-acquisition of muscle mass with ... has been attributed to motor learning. However, this new ... is a cellular ,memory mechanism, within muscle of brief ...
Cached Biology News:Bird buffet requires surveillance 2Nanomaterials database improved to help consumers, scientists track products 2Nanomaterials database improved to help consumers, scientists track products 3Nanomaterials database improved to help consumers, scientists track products 4
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... Super Sensitive MultiLink IHC Detection ... secondary antibodies, labeled with multiple ... the bound primary antibody, and ... Streptavidin-Enzyme conjugate. This kit is ...
BioGenex IHC Kits for Rodent Tissues are designed for immunohistochemistry on rodent and rabbit tissues that are closely related to the source of the primary antibody. This kit comes with rat seconda...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
Biology Products: